Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16854844
[patent_doc_number] => 20210155589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/164825
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164825 | Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide | Jan 31, 2021 | Issued |
Array
(
[id] => 16839421
[patent_doc_number] => 20210147433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 17/153727
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153727 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | Jan 19, 2021 | Issued |
Array
(
[id] => 19491597
[patent_doc_number] => 12110293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Substituted triazolo quinoxaline derivatives
[patent_app_type] => utility
[patent_app_number] => 17/152930
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53873
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 679
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152930 | Substituted triazolo quinoxaline derivatives | Jan 19, 2021 | Issued |
Array
(
[id] => 17905454
[patent_doc_number] => 11459297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt
[patent_app_type] => utility
[patent_app_number] => 17/151901
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7722
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151901 | Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt | Jan 18, 2021 | Issued |
Array
(
[id] => 18802301
[patent_doc_number] => 11835457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Fluorescent composition for detecting biological material
[patent_app_type] => utility
[patent_app_number] => 17/151680
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4756
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151680 | Fluorescent composition for detecting biological material | Jan 18, 2021 | Issued |
Array
(
[id] => 16961500
[patent_doc_number] => 20210212999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/151577
[patent_app_country] => US
[patent_app_date] => 2021-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151577 | USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE | Jan 17, 2021 | Pending |
Array
(
[id] => 16991706
[patent_doc_number] => 20210230126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/146067
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146067 | ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME | Jan 10, 2021 | Abandoned |
Array
(
[id] => 17236594
[patent_doc_number] => 11180465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Benzothia(di)azepine compounds and their use as bile acid modulators
[patent_app_type] => utility
[patent_app_number] => 17/144923
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 44077
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144923 | Benzothia(di)azepine compounds and their use as bile acid modulators | Jan 7, 2021 | Issued |
Array
(
[id] => 16885286
[patent_doc_number] => 20210171481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/144622
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144622 | Benzothia(di)azepine compounds and their use as bile acid modulators | Jan 7, 2021 | Issued |
Array
(
[id] => 16991746
[patent_doc_number] => 20210230166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/142202
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142202 | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS | Jan 4, 2021 | Abandoned |
Array
(
[id] => 17974321
[patent_doc_number] => 11491158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/140471
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21969
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140471 | N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors | Jan 3, 2021 | Issued |
Array
(
[id] => 19563502
[patent_doc_number] => 12138252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Multikinase inhibitors of VEGF and TGF beta and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/137195
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3132
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137195 | Multikinase inhibitors of VEGF and TGF beta and uses thereof | Dec 28, 2020 | Issued |
Array
(
[id] => 19012991
[patent_doc_number] => 11919906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Crystal form of ACP-196 and method of treatment thereof
[patent_app_type] => utility
[patent_app_number] => 17/133521
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6834
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133521 | Crystal form of ACP-196 and method of treatment thereof | Dec 22, 2020 | Issued |
Array
(
[id] => 16915787
[patent_doc_number] => 20210188879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => CHEMICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/133515
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133515 | Chemical compounds | Dec 22, 2020 | Issued |
Array
(
[id] => 16900709
[patent_doc_number] => 20210179625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/126524
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126524 | ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF | Dec 17, 2020 | Abandoned |
Array
(
[id] => 17126144
[patent_doc_number] => 20210300912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/126514
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126514 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | Dec 17, 2020 | Abandoned |
Array
(
[id] => 19397079
[patent_doc_number] => 12071420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
[patent_app_type] => utility
[patent_app_number] => 17/125650
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8307
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125650 | Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2 | Dec 16, 2020 | Issued |
Array
(
[id] => 17784637
[patent_doc_number] => 11407749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Heterocyclic compounds as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 17/119488
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28515
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1695
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119488 | Heterocyclic compounds as immunomodulators | Dec 10, 2020 | Issued |
Array
(
[id] => 16726442
[patent_doc_number] => 20210093589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => N-ACYLETHANOLAMIDE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/116414
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116414 | N-acylethanolamide derivatives and uses thereof | Dec 8, 2020 | Issued |
Array
(
[id] => 16870039
[patent_doc_number] => 20210163506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => BORON-CONTAINING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/115514
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/115514 | Boron-containing compounds | Dec 7, 2020 | Issued |